Mike Motion has over 35 years of corporate experience in medical devices and pharmaceuticals.
He started his commercial career at Baxter Healthcare in 1984 working in manufacturing, sales and marketing and commercial leadership roles at UK, European and global levels. This was across a number of therapeutic areas including nutrition, infectious diseases and oncology.
Mr Motion joined Biocompatibles in 2005 to lead the commercialisation of its interventional oncology portfolio, setting up a direct sales force in the US and a global network of distributors in EMEA, APAC, China and Japan. At BTG, Mr Motion held senior leadership roles as general manager of interventional oncology and head of digital innovation, developing and executing BTG's digital health strategy in the therapeutic areas of oncology, anti-venom, vascular disease and respiratory. Latterly, he was head of Varithena, the only NDA approved treatment for Chronic Venous Insufficiency, securing CPT coding and extensive payer coverage ahead of successful commercialisation in the US
